Skip to content

Survival analysis in pT1-3 and paracolic lymph node invasion colorectal cancer: The prognostic role of P-LNR for adjuvant therapy

Survival analysis in pT1-3 and paracolic lymph node invasion colorectal cancer: The prognostic role of P-LNR for adjuvant therapy

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300076883
Enrollment
Unknown
Registered
2023-10-23
Start date
2022-06-01
Completion date
Unknown
Last updated
2023-10-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colorectal cancer

Interventions

0-4 cycles group (sub-group):None
8 cycles group (sub-group):None
pT1-3N0M0 group:None
pT1-3N+(P-LNR=0.15)M0 group:None
pT4N0M0 group:None
Stage III CRC patients except for pathological pT1-3N+(P-LNR=0.15)M0 group:None

Sponsors

Guangdong Hospital of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Clinically diagnosed as primary colorectal adenocarcinoma; 2. Age 18-75, no gender limit; 3. Undergo radical surgery for colorectal cancer.

Exclusion criteria

Exclusion criteria: 1. Distant metastasis that cannot be curatively resected; 2. Neoadjuvant chemoradiotherapy before surgery; 3. Emergency surgery is performed due to perforation, bleeding, intestinal obstruction, etc. caused by tumors; 4. Palliative tumor resection; 5. Less than 12 lymph nodes are detected after surgery; 6. Pathologically confirmed non-adenocarcinoma; 7. Important clinical data are incomplete; 8. Lost to follow-up due to various reasons during the follow-up period.

Design outcomes

Primary

MeasureTime frame
Cverall survival;

Secondary

MeasureTime frame
Disease free survival;Chemotherapy side effects;General physiological index;Tumor pathology;Lymph node metastasis;Tumor pathological staging;

Countries

China

Contacts

Public ContactDechang Diao

Guangdong Provincial Hospital of Chinese Medicine

diaodechang223@163.com+86 138 2588 8937

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 7, 2026